Indications
- Fatty Liver
- Acute & Chronic infective Hepatitis
- Hepatitis-B positive
- ALD (Alcoholic Liver Disorder)
- Liver Cirrhosis
- Drug induced Hepatitis
Mode of Action
- Works antagonist to hepatotoxic drugs
- Inhibits Hepatitis B core antigen
Dosage: 10 ml Syrup BD
Each 10 ml syrup contains extracts equivalent to:
| Ingredients |
Quantity |
| Bhumiamalaki (Phyllanthus amarus) |
300 mg |
| Kalmega (Andrographis paniculata) |
100 mg |
| Kutaki (Picrorhiza kurroa) |
100 mg |
| Kalmegh (Andrographis paniculata) |
100 mg |
| Pippali (Piper longum) |
50 mg |
References:
-
Antiviral properties of ent-labdene diterpenes of Andrographis
paniculata nees.
C. Wiart, K. M. Y. Yusof, H. Hamimah, Z. M. Fauzi, M. Sulaiman.
Phytotherapy Research Vol 19, Issue 12, pages 1069-1070, December 2005.
-
Singh RP, Banerjee S, Rao AR.
Modulatory influence of Andrographis paniculata on mouse hepatic and
extrahepatic carcinogen metabolizing enzymes and antioxidant
status.
Phytother Res 2001;15:382-390.
-
Antihepatotoxic effect of Picrohiza kurroa on mitochondrial defence
system in anti tubercular drugs induced hepatitis.
R. Jekumar R Rajesh et al.
Journal of medicine in plant research Vol (21) pp. 017-019 Jan 2008.
-
Santra A, Das S, Maity A, Rao SB, Mazumder DN.
Prevention of carbon tetrachloride-induced hepatic injury in mice by
Picrohiza kurroa.
Indian J Gastroenterol. Jan; 17(1): 6-9.
-
Effect of Phyllanthus amarus on chronic carriers of hepatitis B
virus.
Thyagarajan SP, Subramanian S, Thirunalasundari T,
Venkateswaran PS, Blumberg BS.
Lancet 1988 Oct 1;2(8614):764-6.
